Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- Check7 days agoChange DetectedNo additions or deletions were reported; the page content remains unchanged according to the provided changes data.SummaryDifference0.1%

- Check14 days agoChange DetectedMelanoma is added under the MedlinePlus Genetics related topics section, and MedlinePlus Genetics is listed as a related topic on the page. This update provides an additional consumer health information resource connected to the study.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov software/release revision (moving from v3.5.2 to v3.5.3).SummaryDifference0.1%

- Check29 days agoChange DetectedAdded Revision: v3.5.2. Deleted items include Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.5.0.SummaryDifference0.2%

- Check36 days agoChange DetectedAdded Melanoma as a topic and linked MedlinePlus Genetics as a related topic on the study page to improve navigation.SummaryDifference0.2%

- Check43 days agoChange DetectedRemoved related topics entries for Melanoma and MedlinePlus Genetics from the page.SummaryDifference0.2%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.